Glioma shows diffuse infiltrative growth in the brain parenchyma. Even following the
principle of" maximum safe resection", the residual tumor cells are resistant to adjuvant …

Objectives Glioma is the most common malignant tumor of the brain and the intracranial
dissemination of gliomas is the late stage of the development of the tumor. However, there is …

Glioblastoma (GBM) is the most malignant brain tumor in adults and shows an extremely
poor prognosis, with a median survival of 15 months [1]. The main reason for this poor …

Gliomas are the most common intracranial tumors. In the US, approximately 15,000 patients
die with glioblastoma per year (CBTRUS 2002). Despite modern diagnostics and treatments …

Glioblastoma is the most aggressive brain cancer with the poor survival rate. A microRNA,
miR-451, and its downstream molecules, CAB39/LKB1/STRAD/AMPK, are known to play a …

Aims and background Although glioblastomas infiltrate diffusely into adjacent brain, it is
difficult to unequivocally identify the solitary invading glioma cell. It is necessary to develop …

Glioblastoma (GBM) is a very destructive nervous system tumor, and it is almost incurable.
The clinical therapeutic strategies of GBM mainly include surgical resection, combined with …

Diffuse human gliomas constitute a group of most treatment-refractory tumors even if
maximum treatment strategies including neurosurgical resection followed by combined radio …

Generally, gliomas do not metastasize. Therefore, larger series are not available to
investigate the pathways of tumour spread. Here, we present the case of a young man with a …

Glioblastoma (GBM) is one of the most devastating cancers, with an approximate median
survival of only 16 months. Although some new insights into the fantastic heterogeneity of …